Literature DB >> 8403343

Serum cholesterol. Doing the right thing.

J Stamler, R Stamler, W V Brown, A M Gotto, P Greenland, S Grundy, D M Hegsted, R V Luepker, J D Neaton, D Steinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8403343     DOI： 10.1161/01.cir.88.4.1954

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

Review 1.  Implications of the heart protection study for reducing coronary events in high-risk patients.

Authors:  William Virgil Brown; Warren Davis; Matthey Harris
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

2.  Statistical problems.

Authors:  G Davey Smith; M Egger
Journal:  BMJ       Date:  1994-04-16

3.  Low serum total cholesterol concentrations and mortality in middle aged British men.

Authors:  G Wannamethee; A G Shaper; P H Whincup; M Walker
Journal:  BMJ       Date:  1995-08-12

4.  Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study.

Authors:  T E Strandberg; V V Salomaa; H T Vanhanen; V A Naukkarinen; S J Sarna; T A Miettinen
Journal:  Br Heart J       Date:  1995-10

5.  Cardiovascular risk and risk reduction: a review of recent literature.

Authors:  T Theodorson
Journal:  J Family Community Med       Date:  1995-01

6.  Prevalence of selected cardiometabolic risk factors among adults in urban and semi-urban hospitals in four sub-Saharan African countries.

Authors:  Samuel Kingue; Solofonirina Rakotoarimanana; Nirina Rabearivony; Francois Lepira Bompera
Journal:  Cardiovasc J Afr       Date:  2016-08-22       Impact factor: 1.167

7.  Muricholic Acids Promote Resistance to Hypercholesterolemia in Cholesterol-Fed Mice.

Authors:  Dany Gaillard; David Masson; Erwan Garo; Maamar Souidi; Jean-Paul Pais de Barros; Kristina Schoonjans; Jacques Grober; Philippe Besnard; Charles Thomas
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

Review 8.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.